F-group (family)
75.1.1.1 Pro_isomerase
Ligands and drugs
1,540
Member domains
336
with ligand contacts (≤ 4 Å)
21.8% of members
245
with DrugDomain annotations
15.9% of members
130
with a DrugBank compound
8.4% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 75.1.1.1 belongs to X-group 75 Cyclophilin-like, which binds 6.9 ligand superclasses per 20 proteins, narrower than 62% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB00172 | PRO | Proline | 15 |
| DB00160 | ALA | Alanine | 5 |
| DB09459 | TLA | L-tartaric acid | 5 |
| DB02078 | PG5 | Triglyme | 4 |
| DB00133 | SER | Serine | 3 |
| DB00145 | GLY | Glycine | 3 |
| DB00091 | — | — | 2 |
| DB00139 | SIN | Succinic acid | 2 |
| DB03345 | BME | Mercaptoethanol | 2 |
| DB03393 | SFA | Sanglifehrin A | 2 |
| DB03508 | ME2 | Diethylene glycol ethyl methyl ether | 2 |
| DB04447 | DTT | 1,4-Dithiothreitol | 2 |
| DB00117 | HIS | Histidine | 1 |
| DB01742 | 1P3 | (3r)-1-Acetyl-3-Methylpiperidine | 1 |
| DB02419 | E1P | Ethyl Oxo(Piperidin-1-Yl)Acetate | 1 |
| DB03556 | PE5 | 2-(2-{2-[2-(2-{2-[2-(2-Ethoxy-Ethoxy)-Ethoxy]-Ethoxy}-Ethoxy)-Ethoxy]-Ethoxy}-Ethoxy)-Ethanol, Polyethyleneglycol Peg400 | 1 |
| DB08168 | — | Coumarin 120 | 1 |
| DB09130 | — | — | 1 |
| DB09355 | BS4 | Sulfabenzamide | 1 |
| DB11638 | — | — | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| CL | CHLORIDE ION | 30 |
| ZNI | (1R,5S,6r)-N-[(1P,7S,9S,13S,20M)-20-{5-(4-cyclopropylpiperazin-1-yl)-2-[(1S)-1-methoxyethyl]pyridin-3-yl}-21-ethyl-17,17-dimethyl-8,14-dioxo-15-oxa-4-thia-9,21,27,28-tetraazapentacyclo[17.5.2.1~2,5~.1~9,13~.0~22,26~]octacosa-1(24),2,5(28),19,22,25-hexaen-7-yl]-3-oxabicyclo[3.1.0]hexane-6-carboxamide | 30 |
| A1AHB | (1R,2S)-N-[(1P,7S,9S,13R,20M)-21-ethyl-20-{2-[(1R)-1-methoxyethyl]-5-(4-methylpiperazin-1-yl)pyridin-3-yl}-17,17-dimethyl-8,14-dioxo-15-oxa-4-thia-9,21,27,28-tetraazapentacyclo[17.5.2.1~2,5~.1~9,13~.0~22,26~]octacosa-1(24),2,5(28),19,22,25-hexaen-7-yl]-2-methylcyclopropane-1-carboxamide | 22 |
| ZNmetal | ZINC ION | 10 |
| CAmetal | CALCIUM ION | 8 |
| MGmetal | MAGNESIUM ION | 8 |
| NAmetal | SODIUM ION | 8 |
| PRO | PROLINE | 7 |
| Kmetal | POTASSIUM ION | 6 |
| P6G | HEXAETHYLENE GLYCOL | 6 |
| EA4 | ethyl N-[(4-aminobenzyl)carbamoyl]glycinate | 5 |
| TLA | L(+)-TARTARIC ACID | 5 |
| 7HG | 3-[(3-hydroxyphenyl)methyl]-10,12-dimethoxy-9,11-dimethyl-6-(propan-2-yl)-19-oxa-1,4,7,25-tetraazabicyclo[19.3.1]pentacosa-13,15-diene-2,5,8,20-tetrone | 4 |
| WHL | N,N'-(1,4-phenylene)diacetamide | 4 |
| ALA | ALANINE | 3 |
| GLY | GLYCINE | 3 |
| PG5 | 1-METHOXY-2-[2-(2-METHOXY-ETHOXY]-ETHANE | 3 |
| XPE | 3,6,9,12,15,18,21,24,27-NONAOXANONACOSANE-1,29-DIOL | 3 |
| 7I6 | 1-(4-aminobenzyl)-3-[(2S)-4-(methylsulfanyl)-1-{(2R)-2-[2-(methylsulfanyl)phenyl]pyrrolidin-1-yl}-1-oxobutan-2-yl]urea | 2 |
| A1AOD | 1-[(2E)-4-(dimethylamino)-4-methylpent-2-enoyl]-N-[(2R)-1-{[(2S,6S,8S,10R,14S,21M)-22-ethyl-21-{2-[(1S)-1-methoxyethyl]pyridin-3-yl}-18,18-dimethyl-9,15-dioxo-5,16-dioxa-2,10,22,28-tetraazapentacyclo[18.5.2.1~2,6~.1~10,14~.0~23,27~]nonacosa-1(25),20,23,26-tetraen-8-yl]amino}-3-methyl-1-oxobutan-2-yl]-4-fluoro-N-methylpiperidine-4-carboxamide (non-preferred name) | 2 |